Unbiased quantitative assessment of Her-2 expression of circulating tumor cells in patients with metastatic and non-metastatic breast cancer.

Ligthart, S T; Bidard, F-C; Decraene, C; Bachelot, T; Delaloge, S; Brain, E; Campone, M; Viens, P; Pierga, J-Y; Terstappen, L W M M

Ligthart, S T; Bidard, F-C; Decraene, C; Bachelot, T; Delaloge, S; Brain, E; Campone, M; Viens, P; Pierga, J-Y; Terstappen, L W M M.

Affiliation

Ligthart ST; Medical Cell BioPhysics Group, University of Twente, Enschede, The Netherlands.

Ann Oncol ; 24(5): 1231-8, 2013 May.

Article in En | MEDLINE | ID: mdl-23275633

Subject(s)

Breast Neoplasms/metabolism; Breast Neoplasms/pathology; Neoplastic Cells, Circulating/metabolism; Receptor, ErbB-2/metabolism; Biomarkers, Tumor/metabolism; Female; Humans; Leukocytes/metabolism; Neoplasm Metastasis

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Receptor, ErbB-2 / Neoplastic Cells, Circulating Type of study: Clinical_trials / Guideline Limits: Female / Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2013 Type: Article Affiliation country: Netherlands

Fulltext

XML

PubMed Links

Search on Google